Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Promising HPV Test: Fast, Precise and Low-Cost

09.02.2006


Researchers at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in the group of Markus Schmitt have developed a detection method for human papillomaviruses (HPV) which allows them to identify, in a quick and highly reliable manner, high-risk viruses that cause cervical cancer.



The prime risk factor for cervical cancer is an infection with human papillomaviruses. However, not all HPV types are a health hazard. Scientists distinguish between high-risk types and more harmless family members. There are detection methods available that basically allow one to precisely identify the virus type. However, current methods are not really suitable for large-scale use. In addition, it is not possible to unambiguously detect multiple infections with several different virus types.

An approach developed by virus researchers of the German Cancer Research Center now provides a promising alternative. Markus Schmitt and his colleagues describe their test method in the latest issue of the Journal of Clinical Microbiology*: They first isolate the viral genetic material from a tissue sample, amplify and label it. The enriched DNA material is subsequently mixed with different probes, i.e. small DNA fragments each of which is typical for a specific virus type. If the DNA sequences of the viral DNA under study and the probe are identical, they will bind to each other. The probe thus isolates the unknown DNA from the mixture – a process called hybridization. The probes, in turn, are coupled to tiny plastic beads of different colors, with each type of probe attached to beads of the same color. A reading device measures the amount of hybridized viral DNA on the beads. By their characteristic color, the beads tell us which viral DNA was present in the sample.


Schmitt and his colleagues have developed 22 highly sensitive probes which even make it possible to distinguish HPV types whose genomes vary ever so slightly. In addition, a “universal” probe facilitates detection of yet unknown HPV types. The researchers found out that the genotyping is in no way inferior to previous, more complex investigation methods. It is even more sensitive (a minimum of six different virus types can be detected in one sample) and less error-prone (the results are reproducible at any time). These are excellent prerequisites for using the test as a high-throughput method.

The enriched DNA material from 500 tissue samples can be tested for up to 100 HPV types – all in just one day. Since the test can be performed with relatively little effort and at low costs it is suitable for use in large-scale population studies to investigate distribution, variety and infection behavior of the cancer causing viruses. Moreover, the detection method can help to better assess the effectiveness of a vaccination against the virus. Finally, virus typing would be a useful supplement in routine diagnostics. Particularly women with chronic high-risk HPV infection might benefit from a combination of the new HPV test and a Pap smear, which is part of early cancer diagnosis measures covered by the statutory health insurance.

Cervical cancer is the second most frequent cancer among women worldwide. For 2002, an estimated 493,000 new cases were expected and more than 273,000 women died of cervical cancer in the same year (International Agency for Research on Cancer). The Robert Koch Institute estimated in 2000 that slightly over 6,500 women are newly diagnosed with the disease each year in Germany. The tumor usually develops slowly; precancerous changes are diagnosed in about 50% of cases. If detected early, cervical cancer can be treated and cured without difficulty.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF).

Julia Rautenstrauch | alfa
Further information:
http://www.dkfz.de

More articles from Health and Medicine:

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

nachricht Therapy of preterm birth in sight?
19.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>